pseudohypertension
A STOUNDING advances in the treatment of hy-/ \ pertension have taken place over the past A. A . three decades. ' • 2 With these remarkable additions to therapeutics, it is now possible to approach reduction and control of arterial pressure through inhibition of virtually each and every pressor mechanism underlying hypertensive diseases. As a result, more patients with hypertension are now being recognized; more of these patients are being treated; and more patients are coming under effective control of pressure with antihypertensive drugs.
The question, therefore, of resistance to antihypertensive therapy has become less of a problem. Nevertheless, inherent in this problem is precisely what is meant by resistance to antihypertensive therapy. This requires definition and classification.
Resistant Hypertension: A Definition Resistant hypertension should not be defined by the height or severity of hypertension prior to therapy; even the most severe levels of blood pressure elevation or of vascular disease and its target-organ involvement are eminently treatable and usually controllable. This ability is not because the blood pressure elevation may be simple to control; treatment and therapeutic maneuvers may be complex, and at times, they require great expertise. However, in the main, most patients with high levels of arterial pressure and severe degrees of hypertensive disease should be able to have their blood pressure controlled. Therefore, the definition of resis-tant hypertension must relate to the failure of arterial pressure to become reduced and controlled despite the use of acceptable therapy.
The definition, then, of resistant hypertension depends upon what is agreed to be "acceptable therapy." According to the recent Joint National Committee's third report on the detection, evaluation, and treatment of hypertension, patients with diastolic pressure of 90 mm Hg or more should be treated. 3 In this regard, nonpharmacological modalities are indicated for most patients with mild hypertension, for these ancillary forms of therapy are efficacious in controlling arterial pressure in a large number of patients with mild hypertension and may reduce the number of drugs and dosages required for patients with more severe forms of hypertension in whom pharmacological therapy is indicated. 34 Thus, we arrive at those patients whose arterial pressure remains elevated in spite of adequate pharmacotherapy. In general, inadequate control of arterial pressure may be said to occur in the treated patient whose pressure remains in excess of 160/100 mm Hg. 3 Since resistant hypertension has been defined as persistence of pressure greater than 160/100 mm Hg, the question may be asked as to what might be considered "adequate pharmacotherapy." I define this as taking at least three different pharmacological agents, which include a diuretic agent plus two of the following classes of antihypertensive drugs: a /3-adrenergic receptor blocking drug or another antiadrenergic agent, a vasodilator or a calcium entry blocking drug, and an angiotensin converting enzyme inhibitor.
Resistant Hypertension: A Classification There are probably three major categories that place the problem of resistant hypertension into the proper perspective (Appendix, Of the three questions just posed, perhaps the problem of physician resistant hypertension should take primacy in the late 1980s. In these times, the patient is usually interested in having the problem for which he sought attention taken care of, and as indicated, the question of the resistance of the disease has become less of a problem as our therapy has become more specific and efficacious.
With respect to physician resistant hypertension, I refer to one major clinical concern: the adequacy of patient education. Not infrequently, the patient referred for resistant hypertension is not fully aware of the overall problem of the hypertensive disease. Perhaps the patient is unaware that hypertension is a disease that requires continuous therapy or that there is little need for the patient to tolerate side effects from drug therapy. It is clear from the outset that in establishing a treatment regimen, an overall therapeutic program must be worked out by the physician and the patient together. In this program, it is important to spell out very clearly the severity of that patient's disease, the extent of the involvement of the target organs (i.e., heart, brain, and kidneys), and the rationale for the choice of that patient's therapy.
The possible role of dietary sodium restriction, weight reduction, and alcohol consumption should also be spelled out clearly. 34 While not every patient with essential hypertension is sodium dependent, excessive consumption of dietary sodium will reduce the effectiveness of antihypertensive drugs in general as well as that of the diuretic agents. The literature is providing increasingly clear evidence that patients with hypertension, as a group, weigh more than normotensive individuals and that even with modest reductions in body weight, effective control of arterial pressure can be achieved. 346 Furthermore, even if blood pressure is not controlled, weight reduction may reduce the amount of drugs required and the magnitude of the doses used. 7 Recent literature also points to the fact that excessive alcohol consumption will raise arterial pressure and perhaps nullify the effectiveness of antihypertensive drug therapy.
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It is also clear that failure to recognize drug interactions may be responsible for the resistant hypertension. Aspirin and nonsteroidal anti-inflammatory drugs may serve to nullify the effectiveness of the prescribed antihypertensive drugs, and other drugs, including the oral contraceptives and tricyclic antidepressants, may also antagonize the effectiveness of certain antihypertensive drugs. For example, the tricyclic compounds will prevent entrance of such antihypertensive drugs as guanethidine and guanadrel into the postganglionic nerve ending. 8 As a final consideration in this category, the previously emphasized concern of inaccurate clinical diagnosis of hypertension has been a major problem related to the physician. In this regard, the most common inaccuracy in diagnosis is the superimposition of a secondary form of hypertension in the patient with underlying essential hypertension who had been treated adequately and whose blood pressure had been controlled. The best example of this is the patient who develops an occlusive renal arterial lesion during the course of follow-up and management of essential hypertension. It is also important to point out that an individual having had the diagnosis of one secondary form of hypertension may later develop another secondary hypertension. An example might be the patient who had a pheochromocytoma removed but postoperatively developed occlusion of the renal artery (e.g., development of scar tissue around the renal artery).
Furthermore, the individual with essential hypertension who may have been managed with poor control of pressure may develop better control of arterial pressure with the addition of new forms of antihypertensive therapy, and with this better control of pressure, a secondary cause of hypertension might become apparent. As an example, in recent years, I have personally seen the elaboration of primary hyperaldosteronism with the addition of calcium entry blocking drugs to the treatment program, the diagnosis having become apparent as eventually all other forms of antihypertensive therapy, including the diuretic and potassiumretaining agents, were discontinued. Thus, with the discontinuance of all other forms of therapy and with the excellent control of blood pressure associated with the calcium antagonists, development of hypokalemia and cardiac irritability was apparent, and appropriate diagnostic procedures revealed the diagnosis of primary aldosteronism.
Special consideration must also be given to the inappropriate use of diuretic therapy in patients. Sometimes the diuretic (as with other antihypertensive drugs) may have been discontinued because of side effects and the lack of the patient's willingness to experience side effects associated with therapy. Sometimes this may be related to the choice of the inappropriate diuretic agent. For example, if the patient's renal function is so impaired that a thiazide congener does not promote natriuresis or diuresis, the antihypertensive effectiveness of that agent also will not be demonstrated. However, when a loop-acting diuretic is substituted, control of pressure may be achieved. 9 "" In that regard, the dose of the diuretic may not be adequate, or when the dose of the prescribed diuretic is increased, control of pressure may be achieved. 10 That just described for the lack of effectiveness in considering the diuretics can be conveniently transposed to those situations that involve antihypertensive drugs; however, we use the diuretic as an example of how there may be an inappropriate choice of the antihypertensive agent. The diuretic is selected only because it remains the most commonly used antihypertensive agent. Further discussion on choice of appropriate therapy for resistant hypertension is found elsewhere in this monograph.
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Patient Resistant Hypertension
Most of the time, the literature refers to the problem of the patient's resistance and his or her unwillingness to follow an antihypertensive treatment program as the major cause of resistant hypertension today. Inherent in this problem is the frequently used term "patient compliance." I urge the abandonment of this term because the use of the word compliance is a positive feedback to the overall problem of patient resistant hypertension. Compliance is a term that expresses a very specific physical relationship between pressure and volume, and in this respect, an exact curve expressing the relationship can be described. When one describes the problem of a patient's "noncompliance" to a prescribed therapeutic program, I am reminded of a pressured relationship in which a stick is raised against that patient to make him subservient. According to Webster's, compliance is "giving in to a request, wish, demand, etc.; acquiescence." 12 A second definition is "a tendency to give in to others." Should we not promote the goals of resolving patient resistant hypertension with the use of a concept termed patient adherence to a therapeutic program? Webster's defines adherence as "attachment to a person, cause, party, idea." The second definition is "devotion and support." 13 Therefore, would it not be better to foster a patient's adherence to a prescribed treatment program rather than requiring and demanding patient acquiescence to a sodium-restricted diet, to a weight reduction program, and to the recommendation of reduced alcohol consumption? Thus, when adherence to such a nonpharmacological treatment program does not seem reasonable, an alternative drug treatment program that clearly spells out dosages and potential side effects could be instituted to minimize future lack of adherence.
Resistant Hypertension
This is the category that up until now has been considered the major clinical concern with respect to resistance to antihypertensive therapy and resistant hypertension. Not infrequently, the patient has what might be termed pseudoresistance. That patient may demonstrate office hypertension; that is to say, office blood pressures are always higher than home and ambulatory blood pressures. 3 The patient may demonstrate no evidence of cardiac enlargement or the severity of funduscopic changes and alterations in renal function that might be expected to be associated with blood pressures of the severity that are obtained in the office. This impression of the inconsistency of pressures and the effects of the disease may be supported by home blood pressure measurement and the use of 24-hour ambulatory blood pressure recording devices.
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" 16 In the final analysis, with the ubiquity, of home blood pressure recording instruments, the need for ambulatory blood pressure devices is probably infrequent.
Another form of a false diagnosis of hypertension has been termed pseudohypertension and was described in earlier years by Osier, particularly in the elderly individual. 17 Under these circumstances, the hardened and sclerotic brachial artery is not nearly so compressible as the nonsclerotic vessel, and so falsely elevated pressures are recorded by the physician. When such a diagnosis seems possible, it might be wise for the physician to determine blood pressure by direct intra-arterial measurement.
A far more common form of resistant hypertension has been termedpseudotolerance.'• 2 In the early years of antihypertensive drug therapy, this was frequently observed when the diuretic was not added to the selection of a treatment program that comprised antiadrenergic or vasodilating drugs (or both).' 110 Indeed, under these circumstances, as arterial pressure is initially reduced by these agents, the capillary hydrostatic and renal arterial perfusion pressures are reduced, thereby permitting fluid to enter into the circulation from extravascular sources. The physiological adaptation to the reduced pressure occurs through transcapillary migration and renal sodium and water retention. The net effect is a reexpansion of intravascular volume, nullifying the antihypertensive effectiveness of the initially selected drugs. Control of pressure can then be achieved either by the addition of a diuretic or by an adequate increase of the dosage of the diuretic.
1 ' 2 - 9> 10 Another form of resistant hypertension is related to the selection of appropriate antihypertensive therapy, bearing in mind the pressor mechanisms involved in the pathophysiology of that patient's hypertension and the identification of the selected antihypertensive drug, its mode of action, dosage, frequency of administration, and potential drug interactions. This final consideration is the subject-of a separate discussion in this monograph. Certain of these considerations have already been discussed under "Physician Resistant Hypertension."
Conclusion
Resistant hypertension has become a less frequent clinical problem with the development of improved and more specific antihypertensive drugs, some of which may be used as monotherapy without the additional prescription of a diuretic agent. In general, resistant hypertension may be considered as a failure to control arterial pressure to levels below 160/100 mm Hg despite adequate pharmacotherapy that would include a diuretic agent plus two of the following: )3-adrenergic or other adrenergic-inhibiting agents, a vasodilator or calcium entry blocking drug, and an angiotensin converting enzyme inhibitor. Resistant hyertension may be classified by answering three questions: Is the resistant hypertension physician resistant? Is the patient resistant? Or is the hypertension resistant? Physician resistance frequently can be overcome by improving patient education and defining more clearly the therapeutic regimen. In my opinion, patient resistance can be overcome to a large extent by elimination of the concept of "noncompliance" to a treatment program and by the joint collaboration of the physician and patient toward adherence to a treatment program. Resistance of the hypertensive disease, it-11-70 ANTTHYPERTENSIVE DRUG EFFECTS SUPPL II HYPERTENSION, VOL 11, No 3, MARCH 1988 self, may be considered in terms of pseudoresistance, pseudotolerance, and true resistance to therapy. The approaches to the latter are subjects of other discussions in this monograph. 
